MSH6—co-deleted and silenced along with FBXO11—is subject to inactivation in DLBCL associated with microsatellite instability, increased structural rearrangement and altered mutation signatures [38]. The gene discussed is MSH6; the disease is diffuse large B-cell lymphoma.